ArticleFrontiers in oncology2022

Use of savolitinib as neoadjuvant therapy for non-small cell lung cancer patient with MET exon 14 skipping alterations: A case report.

Yu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.